A New York-based biotech was turning heads during Tuesday’s session after the company announced that interim results from a phase 2a trial of its HT-001 showed that all...

To read the full story on AllPennyStocks.com, click here.

Hoth Therapeutics (NASDAQ:HOTH)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Hoth Therapeutics Charts.
Hoth Therapeutics (NASDAQ:HOTH)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Hoth Therapeutics Charts.